{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:15:41Z","timestamp":1793974541181,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01 HS027623"],"award-info":[{"award-number":["R01 HS027623"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K01AG068365"],"award-info":[{"award-number":["K01AG068365"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011944","name":"School of Public Health, University of California Berkeley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ajpm-online.net","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.amepre.2024.06.009","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T17:13:23Z","timestamp":1718212403000},"page":"558-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tramadol use in U.S. Adults With Commercial Health Insurance, 2005\u20132021"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0506-7936","authenticated-orcid":false,"given":"Christopher Andrew","family":"Basham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7337-1046","authenticated-orcid":false,"given":"Heba","family":"Edrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5805-8430","authenticated-orcid":false,"given":"Krista F.","family":"Huybrechts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine S.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3336-5412","authenticated-orcid":false,"given":"Katsiaryna","family":"Bykov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.amepre.2024.06.009_bib0001","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jemermed.2022.01.004","article-title":"Tramadol use in United States Emergency Departments 2007-2018","volume":"62","author":"Mullins","year":"2022","journal-title":"J Emerg Med"},{"issue":"10","key":"10.1016\/j.amepre.2024.06.009_bib0002","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.5435\/JAAOS-D-23-00806","article-title":"National Trends in Orthopaedic Pain Management from 2016 to 2020","volume":"32","author":"Peterman","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"10.1016\/j.amepre.2024.06.009_bib0003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00520-019-05100-9","article-title":"Use of gabapentinoid medications among US adults with cancer, 2005\u20132015","volume":"28","author":"Fauer","year":"2020","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.amepre.2024.06.009_bib0004","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamainternmed.2020.0989","article-title":"Trends in utilization of prescribed controlled substances in US commercially insured adults, 2004-2019","volume":"180","author":"Bykov","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.amepre.2024.06.009_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain \u2014 United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"10.1016\/j.amepre.2024.06.009_bib0006","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.40152","article-title":"Changing trends in opioid use among patients with rheumatoid arthritis in the United States","volume":"69","author":"Curtis","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.amepre.2024.06.009_bib0007","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11916-019-0777-x","article-title":"Tramadol Prescription over a 4-Year Period in the USA","volume":"23","author":"Bigal","year":"2019","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"10.1016\/j.amepre.2024.06.009_bib0008","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00228-020-03016-6","article-title":"Use of tramadol and other analgesics following media attention and risk minimization actions from regulators: a Danish nationwide drug utilization study","volume":"77","author":"S\u00f8rensen","year":"2021","journal-title":"Eur J Clinical Pharmacol"},{"issue":"5","key":"10.1016\/j.amepre.2024.06.009_bib0009","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/pds.4320","article-title":"A 15-year overview of increasing tramadol utilisation and associated mortality and the impact of tramadol classification in the United Kingdom","volume":"27","author":"Chen","year":"2018","journal-title":"Pharmacoepidemiol Drug Safety"},{"issue":"1","key":"10.1016\/j.amepre.2024.06.009_bib0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/j.pain.0000000000002300","article-title":"Clinical and economic burden of prescribing tramadol and other opioids for patients with osteoarthritis in a commercially insured population in the United States","volume":"163","author":"Silverman","year":"2022","journal-title":"Pain"},{"issue":"127","key":"10.1016\/j.amepre.2024.06.009_bib0011","first-page":"37623","article-title":"Schedule of controlled substances: placement of tramadol into schedule IV. Final rule","volume":"79","year":"2014","journal-title":"Federal Register"},{"key":"10.1016\/j.amepre.2024.06.009_bib0012","unstructured":"Drug Enforcement Administration. Tramadol (Trade Names: Ultram\u00ae, Ultracet\u00ae).; 2023.https:\/\/www.deadiversion.usdoj.gov\/drug_chem_info\/tramadol.pdf"},{"key":"10.1016\/j.amepre.2024.06.009_bib0013","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.biopha.2018.12.085","article-title":"An overview of tramadol and its usage in pain management and future perspective","volume":"111","author":"Subedi","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.amepre.2024.06.009_bib0014","series-title":"Negative Binomial Regression","author":"Hilbe","year":"2011"},{"key":"10.1016\/j.amepre.2024.06.009_bib0015","series-title":"Multilevel Analysis","author":"Snijders","year":"2012"},{"key":"10.1016\/j.amepre.2024.06.009_bib0016","first-page":"M23","article-title":"Responding to reviewers and editors about statistical significance testing","author":"Savitz","year":"2024","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.amepre.2024.06.009_bib0017","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA statement on p -values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Statistician"},{"key":"10.1016\/j.amepre.2024.06.009_bib0018","unstructured":"Food and Drug Administration. FDA Drug Safety Communication: FDA recommends against the continued use of propoxyphene. Published November 19, 2010. Accessed April 30, 2024.https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-recommends-against-continued-use-propoxyphene"},{"issue":"1","key":"10.1016\/j.amepre.2024.06.009_bib0019","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/pop.2019.0220","article-title":"Safety events associated with tramadol use among older adults with osteoarthritis","volume":"24","author":"Musich","year":"2021","journal-title":"Population Health Management"},{"issue":"8","key":"10.1016\/j.amepre.2024.06.009_bib0020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2014.9405","article-title":"Management of persistent pain in the older patient: a clinical review","volume":"312","author":"Makris","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.amepre.2024.06.009_bib0021","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J Am Geriatrics Soc"},{"issue":"11","key":"10.1016\/j.amepre.2024.06.009_bib0022","doi-asserted-by":"crossref","first-page":"298","DOI":"10.15585\/mmwr.mm6911a5","article-title":"Variation in adult outpatient opioid prescription dispensing by age and sex \u2014 United States, 2008\u20132018","volume":"69","author":"Schieber","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.amepre.2024.06.009_bib0023","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/bja\/aet127","article-title":"Sex differences in pain: a brief review of clinical and experimental findings","volume":"111","author":"Bartley","year":"2013","journal-title":"British Journal of Anaesthesia"},{"issue":"15","key":"10.1016\/j.amepre.2024.06.009_bib0024","doi-asserted-by":"crossref","first-page":"379","DOI":"10.15585\/mmwr.mm7215a1","article-title":"Chronic pain among adults \u2014 United States, 2019\u20132021","volume":"72","author":"Rikard","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.amepre.2024.06.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.0665","article-title":"Trends and patterns of geographic variation in opioid prescribing practices by state, United States, 2006-2017","volume":"2","author":"Schieber","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.amepre.2024.06.009_bib0026","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","article-title":"Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates","volume":"35","author":"Dowell","year":"2016","journal-title":"Health Affairs"},{"issue":"4","key":"10.1016\/j.amepre.2024.06.009_bib0027","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/pds.4404","article-title":"Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: a comparative interrupted time series analysis","volume":"27","author":"Chang","year":"2018","journal-title":"Pharmacoepidemiology and Drug"},{"issue":"2","key":"10.1016\/j.amepre.2024.06.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0216","article-title":"Patterns of immediate-release and extended-release opioid analgesic use in the management of chronic pain, 2003-2014","volume":"1","author":"Hwang","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amepre.2024.06.009_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8847777","article-title":"Use of tramadol or other analgesics in patients treated in the emergency department as a risk factor for opioid use","volume":"2020","author":"Machado-Alba","year":"2020","journal-title":"Pain Research and Management"},{"issue":"4","key":"10.1016\/j.amepre.2024.06.009_bib0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.15441\/ceem.21.161","article-title":"Pain management in the emergency department: a clinical review","volume":"8","author":"Motov","year":"2021","journal-title":"Clin Exp Emerg Med"},{"issue":"1","key":"10.1016\/j.amepre.2024.06.009_bib0031","first-page":"31","article-title":"Utilization, spending, and price of opioid medications in the US medicaid programs between 1991 and 2019","volume":"15","author":"Alsultan","year":"2022","journal-title":"Am Health Drug Benefits"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379724001995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379724001995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T02:43:50Z","timestamp":1728355430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379724001995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0749379724001995"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2024.06.009","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tramadol use in U.S. Adults With Commercial Health Insurance, 2005\u20132021","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2024.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}